# Clustering Approach 3 : CN_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.693791396717653	Range of duration = 0.03 to 223.96, nDeath = 81, nCensor = 173
2	AGE	ANOVA	1.51940393320436e-05	Range of values = 38 to 86, Mean = 65.4008, StdDev = 9.67837, nMissing = 31
3	GENDER	Fisher's exact test	0.675162987563834	nTypes = 2 (FEMALE/MALE), nPatients = 156/132
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.364808473691855	Range of values = 0 to 100, Mean = 74.2308, StdDev = 33.7251, nMissing = 262
5	HISTOLOGICAL.TYPE	Chi-square test	0.12539016563636	nTypes = 11 (LUNG ACINAR ADENOCARCINOMA/LUNG ADENOCARCINOMA MIXED SUBTYPE/LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS)/LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS/LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS/LUNG CLEAR CELL ADENOCARCINOMA/LUNG MICROPAPILLARY ADENOCARCINOMA/LUNG MUCINOUS ADENOCARCINOMA/LUNG PAPILLARY ADENOCARCINOMA/LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA/MUCINOUS (COLLOID) ADENOCARCINOMA), nPatients = 6/65/182/3/10/2/3/2/10/1/4
6	PATHOLOGY.T	Chi-square test	0.605093969464836	nTypes = 4 (T1/T2/T3/T4), nPatients = 80/169/22/16, nMissing = 1
7	PATHOLOGY.N	Chi-square test	0.803384889363137	nTypes = 3 (N0/N1/N2+N3), nPatients = 172/58/52, nMissing = 6
8	PATHOLOGICSPREAD(M)	Chi-square test	0.853311524947772	nTypes = 3 (M0/M1/MX), nPatients = 202/16/63, nMissing = 7
9	TUMOR.STAGE	Chi-square test	0.125399488362766	nTypes = 4 (I/II/III/IV), nPatients = 149/61/57/16, nMissing = 5
10	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.301677083490386	nTypes = 2 (NO/YES), nPatients = 19/269
11	NEOADJUVANT.THERAPY	Fisher's exact test	0.461323070915811	nTypes = 2 (NO/YES), nPatients = 44/244